Biotech Startups

0 investors

Vita Imaging is a medical technology company developing AURA™, a non-invasive imaging and spectroscopy device that uses Raman spectroscopy and machine learning to distinguish benign from malignant skin lesions in real time for point-of-care cancer screening. It builds physician decision-support diagnostic systems aimed at healthcare providers for early cancer detection.

0 investors

0 investors

Vitanova Biomedical develops cancer treatments based on a proprietary light-activated intracellular acidosis (LAIA) therapy that uses upconverting nanoparticles and deep-penetrating light to induce cancer cell death. The company operates in the biomedical and oncology therapeutics space.

0 investors

0 investors

Vitro Biopharma is a biotechnology company developing Wharton's jelly-derived (umbilical cord) mesenchymal stem cell therapies for autoimmune diseases and inflammatory disorders. It manufactures its cell therapy product candidates under cGMP conditions with ISO 9001:2015 and ISO 13485:2016 certification for the immunology and inflammation market.

0 investors

0 investors

Vitruvias Therapeutics was a pharmaceutical company; it has ceased operations, and its products are now owned and/or distributed by H2-Pharma LLC.

0 investors

Vivakor operates an integrated midstream platform providing crude oil transportation via trucking and pipeline networks, terminaling and storage services at strategically located facilities, and commodity marketing and trading across major U.S. producing basins including the Permian, Eagle Ford, and STACK plays. The company serves oil producers, refiners, and marketers with integrated logistics solutions, and is developing remediation processing capabilities to recover hydrocarbons from oilfield waste.

0 investors

Vivamed develops a minimally invasive neuromodulation treatment for obstructive sleep apnea. The company operates in the medical device and sleep health space.

0 investors

Vivera Pharmaceuticals is a pharmaceutical company. The available page content is a press release about litigation and provides little detail on the company's specific products.

0 investors

0 investors

0 investors

Vivos Inc. is a medical device company developing Precision Radionuclide Therapy (PRnT), a treatment that delivers targeted radiation directly into cancerous tumors via an injectable radionuclide device. Its technology is applied to cancer treatment in humans (RadioGel) and animals (IsoPet), operating in the precision oncology and radionuclide therapy space.

0 investors

0 investors

0 investors

0 investors

Volition develops Nu.Q epigenetics-based blood tests that detect nucleosome changes associated with cancer, sepsis, and other diseases in both humans and animals. Its products include diagnostic assays for NETosis detection, research-use assays, and a canine cancer blood test.

0 investors

0 investors

Voximetry conducts PHS-funded research activities, including basic and applied research and product development related to public health. This page is the company's financial conflict of interest (FCOI) policy rather than a product description.

0 investors

0 investors

0 investors

0 investors

0 investors